StockData
Ingevity Corp logo

Ingevity Corp (NGVT) stock

NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3077% above fair value
$59.28−0.74 (-1.23%)

Close on Nov 17, 2026Market cap $2.04BP/E 40.3Yield –

Ingevity total assets

Total assets on the balance sheet at the end of each period.

Ingevity's total assets was $1.54B at Jun 30, 2026. For fiscal 2025 it was $1.65B, down 18.4% from the year before. Over ten years it grew 7.8% a year on average. The highest annual figure on record is $2.74B in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.65B-18.4%
FY2024Dec 31, 2024$2.02B-22.9%
FY2023Dec 31, 2023$2.62B-4.1%
FY2022Dec 31, 2022$2.74B+10.8%
FY2021Dec 31, 2021$2.47B+5.8%
FY2020Dec 31, 2020$2.33B+9.0%
FY2019Dec 31, 2019$2.14B+62.8%
FY2018Dec 31, 2018$1.32B+41.5%
FY2017Dec 31, 2017$929.60M+11.6%
FY2016Dec 31, 2016$832.80M+6.9%
FY2015Dec 31, 2015$778.70M+8.6%
FY2014Dec 31, 2014$717.30M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.54B-18.1%
Q1 FY2026Mar 31, 2026$1.65B-19.7%
Q4 FY2025Dec 31, 2025$1.65B-18.4%
Q3 FY2025Sep 30, 2025$1.83B-17.1%
Q2 FY2025Jun 30, 2025$1.88B-17.5%
Q1 FY2025Mar 31, 2025$2.06B-19.9%
Q4 FY2024Dec 31, 2024$2.02B-22.9%
Q3 FY2024Sep 30, 2024$2.21B-20.1%
Q2 FY2024Jun 30, 2024$2.28B-19.5%
Q1 FY2024Mar 31, 2024$2.57B-7.4%
Q4 FY2023Dec 31, 2023$2.62B-4.1%
Q3 FY2023Sep 30, 2023$2.77B+18.5%
Q2 FY2023Jun 30, 2023$2.83B+19.5%
Q1 FY2023Mar 31, 2023$2.77B+12.9%
Q4 FY2022Dec 31, 2022$2.74B+10.8%
Q3 FY2022Sep 30, 2022$2.34B-3.7%
Q2 FY2022Jun 30, 2022$2.37B-1.0%
Q1 FY2022Mar 31, 2022$2.46B+4.8%
Q4 FY2021Dec 31, 2021$2.47B+5.8%
Q3 FY2021Sep 30, 2021$2.43B+7.4%
Q2 FY2021Jun 30, 2021$2.39B+8.8%
Q1 FY2021Mar 31, 2021$2.34B-0.5%
Q4 FY2020Dec 31, 2020$2.33B+9.0%
Q3 FY2020Sep 30, 2020$2.26B+6.6%
Q2 FY2020Jun 30, 2020$2.20B+3.1%
Q1 FY2020Mar 31, 2020$2.35B+11.7%
Q4 FY2019Dec 31, 2019$2.14B+62.8%
Q3 FY2019Sep 30, 2019$2.12B+64.0%
Q2 FY2019Jun 30, 2019$2.13B+62.0%
Q1 FY2019Mar 31, 2019$2.11B+68.0%
Q4 FY2018Dec 31, 2018$1.32B+41.5%
Q3 FY2018Sep 30, 2018$1.29B+42.0%
Q2 FY2018Jun 30, 2018$1.31B+50.4%
Q1 FY2018Mar 31, 2018$1.25B+45.6%
Q4 FY2017Dec 31, 2017$929.60M+11.6%
Q3 FY2017Sep 30, 2017$909.80M+7.6%
Q2 FY2017Jun 30, 2017$874.10M–
Q1 FY2017Mar 31, 2017$861.50M–
Q4 FY2016Dec 31, 2016$832.80M–
Q3 FY2016Sep 30, 2016$845.40M–

More Ingevity figures

See a number that looks wrong?